Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

Abstract

The majority of treatment options for cancers are ineffective due to limited therapeutic targeting. Here, the authors develop bispecific antibodies that effectively target nanomaterials to triple-negative breast cancer cell receptors and deliver therapeutics leading to inhibition of tumour growth.